Browse drugs

…dications, such as sodium–glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists, which have been shown to reduce cardiovascular and renal outco…

…atide), or non-GLP-1RA medications (empagliflozin, sitagliptin, glipizide) from 1 December 2017 to 31 December 2023 were included. The as…

… (AIR) therapies that combine inhaled corticosteroids (ICS) and formoterol for newly diagnosed asthma and patients treated with SABA only.…

… placebo for 16 weeks with a 5 week washout then transferred to Selegiline for 16 weeks. Twenty seven patients were kept on Sinemet (mean …

…native treatments. Some PROs indicated greater improvement with semaglutide versus alternative treatment. No new safety concerns were ident…

… 10 mg monotherapy led to notable CBR rates and ALP reductions. Seladelpar monotherapy was well tolerated and had a similar safety profile…

…iratory events. According to the Delhi model2, 50% responded to terlipressin. Duration of terlipressin and time from admission to terlipress…

… ambulatory spinal anesthetics, with prilocaine, lidocaine, and mepivacaine as additional options depending on procedure length and patient…

…for paediatric UC patients appears to yield similar outcomes to Infliximab. Given these findings, weighing cost-effectiveness and the bene…

…will benefit most from medications such as SGLT2-inhibitors and GLP1-RA (unpublished). Thirdly, we were unable to assess on the predict…

…95% CI 5.0% to 7.6%), and it was 3.4% (95% CI 2.7% to 4.2%) for marijuana. The prevalence of dual use of alcohol and cigarettes was 3.1% …

…MARRS study, Millipede88 achieved higher first pass effect than Millipede70. Performance with Millipede70 declined as vessel diameter incre…